Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IMNN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: bearish
Last trade: sell 43 days ago
Red flags: 0
22 filers reported a long position in IMNN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $257.7K | 144.8K | -58.4% |
| Riverview Capital Advisers, LLC | $247.8K | 34.4K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $83.6K | 47K | -2.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $56.3K | 31.6K | -4.8% |
| Virtu Financial LLC | $31K | 17.5K | New |
| VANGUARD FIDUCIARY TRUST CO | $23.6K | 13.3K | Unchanged |
| NORTHERN TRUST CORP | $18.4K | 10.3K | New |
| UBS Group AG | $9.3K | 5.2K | +804.9% |
| BlackRock, Inc. | $7.9K | 4.5K | Unchanged |
| Tower Research Capital LLC (TRC) | $7K | 4K | +111.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.